Historically Starpharma have always raised capital to keep the cash balance above $30m.
On that form, a capital raising this quarter would be appropriate and required, but seriously how could they?
Institutional investors have been dumping during the last 6 months. I doubt Cheryl would want to pitch her first capital raising as CEO at 10 cents.
A serious dilutive 150 million shares issued at 10 cents to raise $15m ???
Perhaps they’ll wait, but for how long can they afford to if there is no DEP deal (s) forthcoming? General consensus is that a company should raise capital before the market wakes to the fact that you need to raise capital.
Thoughts….
Capital raising this Quarter ?
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |